Dostinex

Description

General information about Dostinex in USACabergoline is a synthetic drug derived from ergot that acts on dopamine receptors in the pituitary gland which is located at the base of the brain. Cabergoline stimulates D2 receptors (a specific type of dopamine receptor) in the anterior pituitary and prevents the production of the hormone prolactin. The approval of cabergoline gradually reduced the use of bromocriptine (Cycloset) for the treatment of hyperprolactinemia (abnormally high levels of prolactin in the blood). Cabergoline may be more effective than bromocriptine, and it has fewer troublesome side effects. Additionally, bromocriptine is administered several times a day while cabergoline has a longer half-life that allows it to be administered twice a week. Cabergoline was first approved by the US FDA for the treatment of hyperprolactinemic disorders (high prolactin levels) on December 23, 1996.Features Dostinex in USACabergoline is used for the treatment of hyperprolactinaemic disorders or abnormally high levels of prolactin in the blood.SIDE EFFECTS: The most common side effects are: • nausea, • headache, • dizziness or lightheadedness, • weakness, • low blood pressure, • constipation, and • stomach pain.Less commonly reported side effects are: • abnormal heart rhythm changes, • upper middle stomach pain, • nosebleeds, and • temporary blindness in half of the visual field in one or both eyes.